Arcus Biosciences, Inc. (RCUS) stock forecast and price target
Price $17.43 · data as of November 13, 2026
12-month price target
Average target$41.00
Upside / downside+135.2%
Analysts12
ConsensusStrong buy
Low $23.00Average $41.00High $50.00
Gold marker: average target · white marker: today’s price ($17.43)
Analyst ratings
Strong buy 1Buy 12Hold 2Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-3.48 | −5.7% | $72M |
| Next fiscal year ends December 31, 2027 | $-3.09 | +11.1% | $56M |
| Next quarter ends December 31, 2026 | $-0.86 | +3.9% | $6M |
| Quarter after ends March 31, 2027 | $-0.88 | +13.3% | $6M |
Consensus of the analysts covering Arcus Biosciences, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.
Frequently asked questions
What is the Arcus Biosciences stock price target?
The average 12-month target from 12 analysts is $41.00, 135.2% above the current price of $17.43 Targets range from $23.00 to $50.00.
Is Arcus Biosciences a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 12 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Arcus Biosciences expected to earn?
Analysts expect EPS of $-3.48 for the fiscal year ending December 31, 2026 and $-3.09 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.